SCHEMBL17241473

SCHEMBL17241473

Cn1c(=O)[nH]c2c3cc(Br)ccc3nc(C3CCOCC3)c21

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CASP3 P42574 2/20 0.36
▸ CSNK2B P67870 2/20 0.35
▸ CSNK2A1 P68400 2/20 0.35
▸ CSNK2A2 P19784 1/20 0.35
▸ PARP14 Q460N5 1/20 0.34
▸ FLT3 P36888 1/20 0.33
▸ GABRA1 P14867 1/20 0.33
▸ GABRG2 P18507 1/20 0.33
▸ GABRB3 P28472 1/20 0.33
▸ GABRA5 P31644 1/20 0.33
▸ GABRA3 P34903 1/20 0.33
▸ GABRA2 P47869 1/20 0.33
▸ GABRA6 Q16445 1/20 0.33
▸ TYMS P04818 1/20 0.33
▸ CDC7 O00311 1/20 0.33
▸ PIM1 P11309 1/20 0.33
▸ BRD4 O60885 1/20 0.33
▸ CREBBP Q92793 1/20 0.33
▸ SLC2A1 P11166 1/20 0.33
▸ SLC2A2 P11168 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18824680 0.88 CSNK2B (0.33) CASP3CSNK2BCSNK2A1CSNK2A2GABRA1
SCHEMBL17241729 0.88 CSNK2B (0.33) CASP3CSNK2BCSNK2A1CSNK2A2GABRA1
SCHEMBL17241470 0.85 POLB (0.35) CASP3GABRA1GABRG2GABRB3GABRA5
SCHEMBL18824719 0.83 IRAK4 (0.34) CSNK2BCSNK2A1CSNK2A2PARP14BRD4
SCHEMBL17241484 0.81 CDK1 (0.36) SLC2A1SLC2A2SLC2A3ATMRXFP1
SCHEMBL17241607 0.81 POLB (0.36) CASP3CSNK2BCSNK2A1PARP14FLT3
SCHEMBL17241436 0.81 ATM (0.41) BRD4ATMPIK3CDPIK3CAPIK3CB
SCHEMBL17241363 0.78 CASP3 (0.36) CASP3CSNK2BCSNK2A1CSNK2A2GABRA1
SCHEMBL18824692 0.77 ATM (0.48) ATMPIK3CDPIK3CAPIK3CB
SCHEMBL18824735 0.76 ATM (0.42) ATMPIK3CA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3371183-A1 IMIDAZO[4,5-C]QUINOLIN-2-ONE COMPOUNDS AND THEIR USE IN TREATING CANCER Astrazeneca AB (SE) 2018-09-12 — — EP disclosed
EP-3370722-A1 IMIDAZO[4,5-C]QUINOLIN-2-ONE COMPOUNDS AND THEIR USE IN TREATING CANCER Astrazeneca AB (SE) 2018-09-12 — — EP disclosed
WO-2017076898-A1 IMIDAZO[4,5-C]QUINOLIN-2-ONE COMPOUNDS AND THEIR USE IN TREATING CANCER ASTRAZENECA AB (SE) 2017-05-11 — — WO disclosed
WO-2017076895-A1 IMIDAZO[4,5-C]QUINOLIN-2-ONE COMPOUNDS AND THEIR USE IN TREATING CANCER ASTRAZENECA AB (SE) 2017-05-11 — — WO disclosed
EP-3140303-A1 IMIDAZO[4,5-C]QUINOLIN-2-ONE COMPOUNDS AND THEIR USE IN TREATING CANCER Astrazeneca AB (SE) 2017-03-15 — — EP disclosed
WO-2015170081-A1 IMIDAZO[4,5-C]QUINOLIN-2-ONE COMPOUNDS AND THEIR USE IN TREATING CANCER ASTRAZENECA AB (SE) 2015-11-12 — — WO disclosed
Send feedback